Consistent with this, a recent multi-omics Mendelian randomization study identified CLU as an AD-causal gene whose brain expression is influenced by DNA methylation in the context of mitochondrial dysfunction and inflammation, further supporting its epigenetic sensitivity in AD [332]. The gene discussed is CLU; the disease is Alzheimer disease.